Regulations.gov document: Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product

retained text

Query: artificial intelligence
Agency: FDA
Type: Rule
Docket: FDA-2025-N-1243

document fetched 2026-08-31 02:48 · canonical https://regulations.gov/document/FDA-2025-N-1243-0021